Evigrade

Isavuconazole

Second-generation systemic triazole antifungal

ATC code: J02AC05

Brand names: Cresemba

Updated · Methodology

Indications

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Inhibits fungal 14-alpha-demethylase (CYP51) – blocks ergosterol synthesis. Active against Aspergillus, Mucorales and some rare fungi. Metabolised by CYP3A4 + CYP3A5; itself inhibits CYP3A4 (weaker than voriconazole and posaconazole) but uniquely SHORTENS QT, making it preferred when QT prolongation is a concern.

Safety

Contraindications

  • Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine)
  • Strong CYP3A4 inhibitors (ketoconazole, high-dose ritonavir)
  • Familial short QT syndrome

Serious adverse effects

  • Hepatotoxicity
  • Anaphylaxis
  • Severe skin reactions

Common adverse effects

  • Nausea, vomiting, diarrhoea
  • Headache
  • Liver transaminase rise
  • Hypokalaemia

Pregnancy: can you take Isavuconazole?

Limited data. EMA recommends only when necessary.

Breastfeeding: can you take Isavuconazole?

Breastfeeding not recommended.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Drug–drug interactions

4 pairs found. Sorted from critical to minor.

CriticalCarbamazepineAntiepileptics. Carboxamide derivatives

Mechanism

Carbamazepine is a strong CYP3A4 inducer. Isavuconazole falls significantly. Cresemba Section 4.3.

Symptoms

Mycosis progression.

Management

Combination contraindicated.

Pair details →Carbamazepine →

CriticalPhenytoinAntiepileptic, hydantoin derivative (sodium channel blocker)

Mechanism

Strong CYP3A4 induction.

Symptoms

Mycosis progression.

Management

Combination contraindicated.

Pair details →Phenytoin →

CriticalRifampicinAntituberculous antibiotic

Mechanism

Rifampicin is a strong CYP3A4 inducer. Isavuconazole falls 97% – antifungal effect lost.

Symptoms

Fungal infection progression.

Management

Combination contraindicated. Cresemba Section 4.3.

Pair details →Rifampicin →

MajorSirolimusSelective immunosuppressant, mTOR inhibitor

Mechanism

Isavuconazole is a moderate CYP3A4 inhibitor. Sirolimus rises 1.5-2 fold.

Symptoms

Nephrotoxicity.

Management

Reduce sirolimus by 50% with blood level monitoring.

Pair details →Sirolimus →

Label mentions7 mentions

Verbatim lines from the interaction sections, in the language of the label

From other drugs’ labels

  • CriticalItraconazole
    «Analgésicos; Anestésicos: Isavuconazol»

    AEMPS, section 4.3 · Open on CIMA

  • «Established and Other Potentially Significant Drug Interactions: Antifungals : itraconazole, isavuconazole, ketoconazole, posaconazole voriconazole ­  darunavir ­  itraconazole ­  isavuconazole ­…»

    FDA, section 7 · Open on DailyMed

  • ModerateDarunavir
    «ANTIMICÓTICOS: Fluconazol Isavuconazol Itraconazol Posaconazol Clotrimazol»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateMetformin
    «Inhibidores de OCT2 (tales como cimetidina, dolutegravir, ranolazina, trimetopreim, vandetanib, isavuconazol) pueden reducir la eliminación renal de metformina y por tanto pueden llevar a un…»

    AEMPS, section 4.5 · Open on CIMA

  • «Medicamentos que afectan a la glucuronidación (por ejemplo, isavuconazol, telmisartán)»

    AEMPS, section 4.5 · Open on CIMA

  • «Effect of Other Drugs on Mycophenolate Mofetil: Examples Telmisartan (induces glucuronidation); isavuconazole (inhibits glucuronidation).»

    FDA, section 7 · Open on DailyMed

  • «Recomendaciones relativas a la a dministración simultánea: Inhibidores del CYP3A4 moderados o débiles: agentes antifúngicos (p. ej., fluconazol, isavuconazol, clotrimazol, miconazol), antibióticos…»

    AEMPS, section 4.5 · Open on CIMA

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Isavuconazole used for?

Isavuconazole is evaluated for the following indications with varying evidence strength: Invasive aspergillosis (evidence tier A). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Isavuconazole?

Common side effects of Isavuconazole (≥ 1 in 100): Nausea, vomiting, diarrhoea, Headache, Liver transaminase rise, Hypokalaemia. See the Safety section for uncommon and serious reactions.

Is Isavuconazole safe during pregnancy?

Limited data. EMA recommends only when necessary.

Is Isavuconazole compatible with breastfeeding?

Breastfeeding not recommended.

Who should not take Isavuconazole?

Isavuconazole is contraindicated in: Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine); Strong CYP3A4 inhibitors (ketoconazole, high-dose ritonavir); Familial short QT syndrome. Full list in the Safety section.

Other drugs in this group

Amphotericin B, Fluconazole, Itraconazole, Ketoconazole, Posaconazole, Voriconazole